Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001828185-25-000037
Filing Date
2025-05-07
Accepted
2025-05-07 08:12:43
Documents
76
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q brns-20250331.htm   iXBRL 10-Q 848855
2 EX-31.1 brns-20250331xexx311.htm EX-31.1 11385
3 EX-31.2 brns-20250331xexx312.htm EX-31.2 11338
4 EX-32.1 brns-20250331xexx321.htm EX-32.1 5669
  Complete submission text file 0001828185-25-000037.txt   4944481

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT brns-20250331.xsd EX-101.SCH 45853
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT brns-20250331_cal.xml EX-101.CAL 63805
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT brns-20250331_def.xml EX-101.DEF 157563
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT brns-20250331_lab.xml EX-101.LAB 526739
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT brns-20250331_pre.xml EX-101.PRE 340963
79 EXTRACTED XBRL INSTANCE DOCUMENT brns-20250331_htm.xml XML 462377
Mailing Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF
Business Address UNIT 6-10, ZEUS BUILDING RUTHERFORD AVENUE, HARWELL DIDCOT X0 OX11 0DF 44 (0) 1865 818808
Barinthus Biotherapeutics plc. (Filer) CIK: 0001828185 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40367 | Film No.: 25919410
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)